Seeing Is Believing
BBI is currently covered by 2 analysts with an average price target of $0.53. This is a potential upside of $-0.37 (-41.11%) from yesterday's end of day stock price of $0.9.
Brickell Biotech's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of BBI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 9.67 days.
Highest price target for BBI is $8, Lowest price target is $3.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HCWAINWRIGHT on 16-Aug-2022. First documented stock forecast 18-Jan-2022.
Currently out of the existing stock ratings of BBI, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4.5
$3.53 (363.92%)
2 years 6 months 18 days ago
(16-Aug-2022)
0/1 (0%)
$1.04 (30.06%)
Buy
$11.25
$10.35 (1150.00%)
2 years 9 months 21 days ago
(13-May-2022)
0/1 (0%)
$2.87 (34.25%)
Buy
$35
2 years 11 months 18 days ago
(16-Mar-2022)
1/1 (100%)
$-5.01 (-12.52%)
29
What is BBI (Brickell Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on BBI (Brickell Biotech) with a proven track record?
Which analyst has the current lower performing score on BBI (Brickell Biotech) with a proven track record?
Which analyst has the most public recommendations on BBI (Brickell Biotech)?
Which analyst is the currently most bullish on BBI (Brickell Biotech)?
Which analyst is the currently most reserved on BBI (Brickell Biotech)?